A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & their work will meaningfully impact lives of patients. 1st study: https://t.co/l9m6SQ5TXm 1-year outcomes: https://t.co/D8Jgsr1fzA https://t.co/oXTh4pf2BG
One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2019 – Sep 2023Where it's discussed
-
X / Twitter16 posts
-
Facebook14 posts
-
News9 articles
-
Blogs4 articles
-
YouTube3 videos
AI synopsis
What people are saying
The responses reflect a positive and eager attitude towards the trial, with wording like 'meaningfully impact lives' and 'important questions resolved,' indicating high regard for its influence. The tone combines respect for the researchers' efforts with anticipation of clinical implications, suggesting a generally favorable perception of the publication's significance.
Most discussions acknowledge the significance of the trial, supporting its findings and implications.
Posts show high interest, referencing specific trials, results, and implications for patient care.
Several discussions demonstrate active engagement by praising researchers and emphasizing impact, though mostly at a surface level.
The discussions highlight the importance of the trial's results, suggesting potential changes in clinical practice or ongoing debates.
Abstract in brief
- The study compared the 1-year outcomes of two PCI strategies in patients with acute myocardial infarction and cardiogenic shock: culprit-lesion-only PCI versus immediate multivessel PCI, finding similar death rates but higher rates of repeat procedures and heart failure hospitalizations with culprit-lesion-only PCI.
- At one year, death occurred in about 50% of patients in both groups, with no significant difference, but recurrent infarctions and unplanned revascularizations were more common in the culprit-lesion-only group.
- While culprit-lesion-only PCI resulted in fewer serious adverse events at 30 days, it was associated with more repeat procedures and rehospitalizations for heart failure over the following year.]
Top posts
Most liked on X and BlueskyAwaited trials on #ECMO & #Impella 1-yr Results of #CulpritShock published @NEJM https://t.co/WLsme9g9tg https://t.co/Avi4puN1Jx
CULPRIT-SHOCK Trial One-Year Outcomes after PCI Strategies in Cardiogenic Shock https://t.co/PL2sq0mumn https://t.co/1LX2PHiwzW
CULPRIT-SHOCK trial 心原性ショックを合併した冠動脈多枝病変症例でさえ、急性期は責任病変のみのPCIの方が予後良好。 https://t.co/I6wYW1sRt7
RT @rohan_khera: A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & thei…
RT @mirvatalasnag: Awaited trials on #ECMO & #Impella 1-yr Results of #CulpritShock published @NEJM https://t.co/WLsme9g9tg https://t.co…
All mentions
ECLS Impact on Cardiogenic Shock: Key Study Insights by Prof. Thiele
Prof. Dr. Holger Thiele presents the central findings of his studies ECLSSHOCK and CAVAADHF at the European Society of Cardiology Congress. ECLSSHOCK explored whether ECLS improves outcomes in cardiogenic shock due to…
Key Cardiological Trials Impacting 2018 Outcomes
This video reviews the top 10 cardiology trials of 2018, highlighting significant studies including those on PCI strategies in cardiogenic shock and the effects of various treatments on cardiovascular outcomes. Discover…
Understanding the German Cardiac Arrest Register and Defibrillation Strategies
In this insightful discussion, Priv.-Doz. Dr. Janine Pöss presents the German Cardiac Arrest Register (G-CAR), an epidemiological study aimed at enhancing the understanding of out-of-hospital cardiac arrest. The video…
Complete shock (Shockあれば病変のみがよいが、心配停止になった人が多いのがリミテーション) https://t.co/0tKmkIOi6Q
RT @rohan_khera: A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & thei…
RT @rohan_khera: A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & thei…
RT @rohan_khera: A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & thei…
RT @rohan_khera: A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & thei…
A shout out to @thiele_holger & colleagues for carrying out CULPRIT-SHOCK - they didn’t contend with the status quo & their work will meaningfully impact lives of patients. 1st study: https://t.co/l9m6SQ5TXm 1-year outcomes: https://t.co/D8Jgsr1fzA https://t.co/oXTh4pf2BG
RT @mirvatalasnag: Awaited trials on #ECMO & #Impella 1-yr Results of #CulpritShock published @NEJM https://t.co/WLsme9g9tg https://t.co…
RT @mirvatalasnag: Awaited trials on #ECMO & #Impella 1-yr Results of #CulpritShock published @NEJM https://t.co/WLsme9g9tg https://t.co…
Awaited trials on #ECMO & #Impella 1-yr Results of #CulpritShock published @NEJM https://t.co/WLsme9g9tg https://t.co/Avi4puN1Jx
Great article: One-Year Outcomes after PCI Strategies in Cardiogenic Shock. https://t.co/o7vS94WBrm #ReadByQxMD Important questions resolved by this paper
Great article: One-Year Outcomes after PCI Strategies in Cardiogenic Shock. https://t.co/o7vS94WBrm #ReadByQxMD Important questions resolved by this paper
CULPRIT-SHOCK trial 心原性ショックを合併した冠動脈多枝病変症例でさえ、急性期は責任病変のみのPCIの方が予後良好。 https://t.co/I6wYW1sRt7
RT @PA_Maday: CULPRIT-SHOCK Trial One-Year Outcomes after PCI Strategies in Cardiogenic Shock https://t.co/PL2sq0mumn https://t.co/1LX2PH…
CULPRIT-SHOCK Trial One-Year Outcomes after PCI Strategies in Cardiogenic Shock https://t.co/PL2sq0mumn https://t.co/1LX2PHiwzW
RT @NEJM: #VisualAbstract: One-Year Outcomes after PCI Strategies in Cardiogenic Shock (CULPRIT-SHOCK trial) https://t.co/pQHnp5PgLc See a…
RT @NEJM: #VisualAbstract: One-Year Outcomes after PCI Strategies in Cardiogenic Shock (CULPRIT-SHOCK trial) https://t.co/pQHnp5PgLc See a…